This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02) | MicrobiomeTrials
← Back to trials NCT06072430
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02) Completed PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-08-06Est. Completion: 2026-06-29
Enrollment target: 39 participantsLocations Dignity Health Chandler Regional Medical Center, Chandler, Arizona, United States Memorial Health University Medical Center, Savannah, Georgia, United States University Health, Kansas City, Missouri, United States Novant Healthcare, Winston-Salem, North Carolina, United States Oregon Health & Science University (OHSU), Portland, Oregon, United States Other microbiome trials you might be interested in ECMO Cannula Infection Extracorporel Membrane Oxygenation Complication
Extracorporeal membrane oxygenation (ECMO) is increasingly used as rescue support in patients with refractory respirator…
Paris, France Est. completion Jan 2029
Septic Shock
Septic shock is a syndrome associated with severe infection and a mortality rate of approximately 45%. In line with curr…
Aix-en-Provence, France Est. completion Feb 2028